Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Trials & Approvals

Updates on new clinical tirals being performed in China, trial updates and drug approvals...

BeyondSpring Starts Rolling Application of China NDA for Neutropenia Treatment

Chi-Med Starts Phase II Trial of FGFR Inhibitor in Mesothelioma Patients

Shenzhen's BGI Genomics Approved to Launch SARS-CoV-2 Test in the US

Fosun Long March's COVID-19 Test Approved in China

CStone Files Taiwan NDA for Precision-Med GIST Candidate

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China